Kingsbury Capital Investment Advisors LLC Corbus Pharmaceuticals Holdings, Inc. Transaction History
Kingsbury Capital Investment Advisors LLC
- $65.6 Million
- Q3 2022
A detailed history of Kingsbury Capital Investment Advisors LLC transactions in Corbus Pharmaceuticals Holdings, Inc. stock. As of the latest transaction made, Kingsbury Capital Investment Advisors LLC holds 33,700 shares of CRBP stock, worth $626,483. This represents 0.01% of its overall portfolio holdings.
Number of Shares
33,700Holding current value
$626,483% of portfolio
0.01%Shares
3 transactions
Others Institutions Holding CRBP
# of Institutions
4Shares Held
38.7KCall Options Held
0Put Options Held
0About Corbus Pharmaceuticals Holdings, Inc.
- Ticker CRBP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 125,268,000
- Market Cap $2.33B
- Description
- Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...